Innate Pharma (IPHA) Short Interest Ratio & Short Volume $1.64 -0.06 (-3.53%) (As of 11/22/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Innate Pharma Short Interest DataInnate Pharma (IPHA) has a short interest of 65,200 shares. This marks a 10.88% increase in short interest from the previous month. The short interest ratio (days to cover) is 7.8, indicating that it would take 7.8 days of the average trading volume of 9,181 shares to cover all short positions.Current Short Interest65,200 sharesPrevious Short Interest58,800 sharesChange Vs. Previous Month+10.88%Dollar Volume Sold Short$123,293.20Short Interest Ratio7.8 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares80,970,000 sharesPercentage of Shares Shorted0.08%Today's Trading Volume7,993 sharesAverage Trading Volume9,181 sharesToday's Volume Vs. Average87% Short Selling Innate Pharma? Sign up to receive the latest short interest report for Innate Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartIPHA Short Interest Over TimeIPHA Days to Cover Over TimeIPHA Percentage of Float Shorted Over Time Ad DTIDownload Our Tesla Ebook For FreeLike many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link. Innate Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/202465,200 shares $123,293.20 +10.9%N/A7.8 $1.89 10/15/202458,800 shares $119,364.00 -18.1%N/A7.4 $2.03 9/30/202471,800 shares $164,422.00 +20.3%N/A10 $2.29 9/15/202459,700 shares $134,922.00 -8.3%N/A9 $2.26 8/31/202465,100 shares $149,404.50 -2.5%N/A9.3 $2.30 8/15/202466,800 shares $150,300.00 +3.6%N/A8.1 $2.25 Get the Latest News and Ratings for IPHA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Innate Pharma and its competitors with MarketBeat's FREE daily newsletter. 7/31/202464,500 shares $138,352.50 -11.5%N/A7.8 $2.15 7/15/202472,900 shares $154,548.00 +5.2%N/A9.1 $2.12 6/30/202469,300 shares $134,442.00 -4.9%N/A7.7 $1.94 6/15/202472,900 shares $171,315.00 +4.1%N/A7 $2.35 5/31/202470,000 shares $191,800.00 -0.3%N/A6.7 $2.74 5/15/202470,200 shares $175,942.26 -11.3%N/A7.2 $2.51 4/30/202479,100 shares $182,721.00 -2.7%N/A8.8 $2.31 4/15/202481,300 shares $196,746.00 +5.7%N/A7.8 $2.42 3/31/202476,900 shares $221,472.00 -13.7%N/A7.7 $2.88 3/15/202489,100 shares $217,404.00 +13.7%N/A7.6 $2.44 2/29/202478,400 shares $205,408.00 -4.9%N/A4.1 $2.62 2/15/202482,400 shares $212,592.00 +8.4%N/A4.7 $2.58 1/31/202476,000 shares $203,680.00 -0.9%N/A4 $2.68 1/15/202476,700 shares $214,760.00 -8.9%N/A3.7 $2.80 12/31/202384,200 shares $235,760.00 +55.9%N/A3.9 $2.80 12/15/202354,000 shares $130,140.00 -5.9%N/A2.6 $2.41 11/30/202357,400 shares $137,760.00 -4.3%N/A4.3 $2.40 11/15/202360,000 shares $147,600.00 -6.0%N/A4.2 $2.46 10/31/202363,800 shares $151,844.00 +11.5%N/A4.4 $2.38 10/15/202357,200 shares $132,418.00 -8.5%N/A5 $2.32 9/30/202362,500 shares $158,125.00 -3.4%N/A6 $2.53 9/15/202364,700 shares $192,159.00 -1.5%N/A6.7 $2.97 8/31/202365,700 shares $191,324.97 -8.1%N/A5.2 $2.91 8/15/202371,500 shares $206,635.00 -3.8%N/A6.1 $2.89 7/31/202374,300 shares $218,442.00 -1.9%N/A6.8 $2.94 7/15/202375,700 shares $244,511.00 -3.8%N/A6.4 $3.23 6/30/202378,700 shares $242,002.50 +20.0%N/A6.1 $3.08 6/15/202365,600 shares $213,856.00 +9.7%N/A4 $3.26 5/31/202359,800 shares $175,812.00 -4.3%N/A3.8 $2.94 5/15/202362,500 shares $186,875.00 No ChangeN/A3.6 $2.99 10/31/2022147,600 shares $317,340.00 +12.8%N/A12.9 $2.15 10/15/2022130,900 shares $261,800.00 +15.5%N/A12.5 $2.00 9/30/2022113,300 shares $226,600.00 +1.3%N/A12.7 $2.00 9/15/2022111,900 shares $284,226.00 +2.3%N/A13.3 $2.54Let’s be blunt (Ad)Let me be blunt with you for just a second… You may think you know when and why stocks move, but you’re wrong… Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight. But once you’ve cracked this code… It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)! Check out the $100 Challenge now 8/31/2022109,400 shares $293,192.00 +0.2%N/A6.4 $2.68 8/15/2022109,200 shares $321,048.00 -10.1%N/A5.9 $2.94 7/31/2022121,500 shares $388,787.85 -3.6%N/A6.1 $3.20 7/15/2022126,000 shares $347,760.00 +0.3%N/A4.9 $2.76 6/30/2022125,600 shares $339,120.00 +3.9%N/A4.8 $2.70 6/15/2022120,900 shares $305,877.00 +1.9%N/A4.6 $2.53 5/31/2022118,700 shares $315,742.00 -13.6%N/A6.2 $2.66 5/15/2022137,300 shares $394,051.00 +8.0%N/A6.7 $2.87 4/30/2022127,100 shares $364,777.00 -9.3%N/A5.7 $2.87 4/15/2022140,100 shares $438,513.00 +4.0%N/A6 $3.13 3/31/2022134,700 shares $452,592.00 +105.0%N/A5.3 $3.36 3/15/202265,700 shares $207,612.00 +13.9%N/A1.6 $3.16 2/28/202257,700 shares $196,757.00 -2.5%N/A1 $3.41 2/15/202259,200 shares $219,632.00 -15.6%N/A0.9 $3.71 1/31/202270,100 shares $265,679.00 -15.3%N/A1 $3.79 1/15/202282,800 shares $375,084.00 -22.3%N/A1.1 $4.53 12/31/2021106,600 shares $486,096.00 +247.2%N/A1.3 $4.56 12/15/202130,700 shares $158,105.00 +0.3%N/A0.3 $5.15 11/30/202130,600 shares $151,776.00 -39.8%N/A0 $4.96 11/15/202150,800 shares $263,652.00 +195.4%N/A0 $5.19 10/29/202117,200 shares $99,760.00 +18.6%N/A0 $5.80 10/15/202114,500 shares $85,115.00 -89.5%N/A0 $5.87 9/30/2021137,800 shares $850,226.00 +79.7%N/A0.1 $6.17 9/15/202176,700 shares $427,986.00 +2,456.7%N/A0 $5.58 8/31/20213,000 shares $10,920.00 -45.5%N/A0 $3.64 8/13/20215,500 shares $18,700.00 -35.3%N/A0.3 $3.40 7/30/20218,500 shares $28,220.00 -33.6%N/A0.5 $3.32 7/15/202112,800 shares $41,472.00 +100.0%N/A0.7 $3.24 6/30/20216,400 shares $21,056.00 -61.0%N/A0.4 $3.29 6/15/202116,400 shares $65,764.00 +1,161.5%N/A1.1 $4.01 5/28/20211,300 shares $5,083.00 +225.0%N/A0.1 $3.91 5/14/2021400 shares $1,580.00 -81.8%N/A0 $3.95 4/30/20212,200 shares $9,416.00 -29.0%N/A0.1 $4.28 4/15/20213,100 shares $13,578.00 -55.7%N/A0 $4.38 3/31/20217,000 shares $30,030.00 -6.7%N/A0.2 $4.29 3/15/20217,500 shares $34,275.00 +53.1%N/A0.2 $4.57 2/26/20214,900 shares $21,658.00 -27.9%N/A0.1 $4.42 2/12/20216,800 shares $30,804.00 +385.7%N/A0.2 $4.53 1/29/20211,400 shares $5,740.00 -74.1%N/A0 $4.10 1/15/20215,400 shares $24,516.00 -77.2%N/A0.2 $4.54 12/31/202023,700 shares $102,147.00 -52.5%N/A0.9 $4.31 12/15/202049,900 shares $219,061.00 +91.2%N/A2.5 $4.39 11/30/202026,100 shares $145,116.00 -7.1%N/A1.5 $5.56 11/15/202028,100 shares $133,475.00 -23.2%N/A1.6 $4.75 10/30/202036,600 shares $146,217.00 +21.6%N/A2.5 $4.00 10/15/202030,100 shares $121,002.00 +32.6%N/A2.5 $4.02 9/30/202022,700 shares $87,168.00 -22.5%N/A2.2 $3.84 9/15/202029,300 shares $127,455.00 +70.4%N/A2.9 $4.35 8/31/202017,200 shares $106,812.00 -5.5%N/A2.2 $6.21 8/14/202018,200 shares $119,210.00 -40.9%N/A2.3 $6.55Let’s be blunt (Ad)Let me be blunt with you for just a second… You may think you know when and why stocks move, but you’re wrong… Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight. But once you’ve cracked this code… It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)! Check out the $100 Challenge now 7/31/202030,800 shares $187,205.48 +76.0%N/A3.3 $6.08 7/15/202017,500 shares $105,175.00 +25.9%N/A2.1 $6.01 6/30/202013,900 shares $88,404.00 -0.7%N/A1.7 $6.36 6/15/202014,000 shares $87,780.00 -23.1%N/A1.4 $6.27 5/29/202018,200 shares $121,030.00 -59.4%N/A1.3 $6.65 5/15/202044,800 shares $300,160.00 +44.5%N/A2.7 $6.70 4/30/202031,000 shares $235,600.00 -13.9%N/A1.9 $7.60 4/15/202036,000 shares $251,100.00 -15.3%N/A2.3 $6.98 3/31/202042,500 shares $320,875.00 -29.9%N/A2.1 $7.55 3/13/202060,600 shares $390,870.00 -5.2%N/A6.5 $6.45 2/28/202063,900 shares $274,770.00 +47.2%N/A2.1 $4.30 2/14/202043,400 shares $298,592.00 +2.4%N/A1.3 $6.88 1/31/202042,400 shares $318,424.00 -1.6%N/A1.2 $7.51 1/15/202043,100 shares $322,388.00 +8.6%N/A1 $7.48 12/31/201939,700 shares $289,016.00 No ChangeN/A0.6 $7.28 IPHA Short Interest - Frequently Asked Questions What is Innate Pharma's current short interest? Short interest is the volume of Innate Pharma shares that have been sold short but have not yet been closed out or covered. As of October 31st, investors have sold 65,200 shares of IPHA short. Learn More on Innate Pharma's current short interest. What is a good short interest ratio for Innate Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IPHA shares currently have a short interest ratio of 8.0. Learn More on Innate Pharma's short interest ratio. Is Innate Pharma's short interest increasing or decreasing? Innate Pharma saw a increase in short interest in the month of October. As of October 31st, there was short interest totaling 65,200 shares, an increase of 10.9% from the previous total of 58,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Innate Pharma's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Innate Pharma: ProKidney Corp. (13.64%), GH Research PLC (6.27%), Zevra Therapeutics, Inc. (7.53%), Esperion Therapeutics, Inc. (17.16%), Terns Pharmaceuticals, Inc. (7.17%), Korro Bio, Inc. (4.43%), MeiraGTx Holdings plc (2.12%), Arcturus Therapeutics Holdings Inc. (18.50%), REGENXBIO Inc. (9.91%), Xeris Biopharma Holdings, Inc. (7.63%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Innate Pharma stock? Short selling IPHA is an investing strategy that aims to generate trading profit from Innate Pharma as its price is falling. IPHA shares are trading down $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Innate Pharma? A short squeeze for Innate Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of IPHA, which in turn drives the price of the stock up even further. How often is Innate Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IPHA, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies ProKidney Short Interest GH Research Short Interest Zevra Therapeutics Short Interest Esperion Therapeutics Short Interest Terns Pharmaceuticals Short Interest Korro Bio Short Interest MeiraGTx Short Interest Arcturus Therapeutics Short Interest REGENXBIO Short Interest Xeris Biopharma Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:IPHA) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innate Pharma S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Innate Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IPHA Stock Alerts